Is Combined Pretransplantation Seropositivity of Kidney Transplant Recipients for Cytomegalovirus Antigens (pp150 and pp28) a Predictor for Protection against Infection?

By  

Medical Principles and Practice, Vol. 17, Iss. 1, 2008-04 ,pp. : 66-70

Karger

Access to resources Recommend Favorite

Efficacy of a strategy for discontinuing pre-emptive ganciclovir therapy after a negative cytomegalovirus antigenaemia test result in seropositive kidney transplant recipients

By Park So-Youn   Kim Young Hoon   Han Duck Jong   Park Su-Kil   Park Jung Sik   Sung Heungsup   Park Hyun Jung   Kim Sung-Han   Choi Sang-Ho   Kim Yang Soo   Woo Jun Hee   Lee Sang-Oh  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 5, 2013-05 ,pp. : 1209-1211

Oxford University Press

Access to resources Recommend Favorite

Virologic Suppression Measured by a Cytomegalovirus (CMV) DNA Test Calibrated to the World Health Organization International Standard Is Predictive of CMV Disease Resolution in Transplant Recipients

By Razonable Raymund R.   sberg Anders   Rollag Halvor   Duncan John   Boisvert Denis   Yao Joseph D.   Caliendo Angela M.   Humar Atul   Do Tri D.  

Clinical Infectious Diseases, Vol. 56, Iss. 11, 2013-06 ,pp. : 1546-1553

Oxford University Press

Access to resources Recommend Favorite

JC viraemia in kidney transplant recipients: to act or not to act?

By Rao N.   Schepetiuk S.   Choudhry M.   Juneja R.   Passaris G.   Higgins G.   Barbara J.  

Clinical Kidney Journal, Vol. 5, Iss. 5, 2012-10 ,pp. : 471-473

Oxford University Press

Access to resources Recommend Favorite

Advances in the cardiovascular assessment of patients with chronic kidney disease

By McIntyre Chris W.   John Stephen G.   Jefferies Helen J.  

NDT PLUS, Vol. 1, Iss. 6, 2008-12 ,pp. : 383-391

Oxford University Press

Access to resources Recommend Favorite